Table 1.
Characteristics of patients for samples
| Patient characteristics | Total | Dysfunctional agr (N = 10) | Functional agr (N = 159) | P-value |
|---|---|---|---|---|
| Male sex, N (%) | 162 (60.22) | 5 (50.00) | 157 (60.62) | 0.5253 |
| Age (months), median (IQRa) | 11.9 (1.27–55.14) | 33.27 (13.15–108.38) | 11.33 (1.17–54.90) | 0.0797 |
| Age distribution | 0.1581 | |||
| ≤ 28 days | 59 (21.93) | 0 | 59 (22.78) | |
| 29 days–3 years | 137 (50.93) | 7 (70.00) | 130 (50.19) | |
| 4–6 years | 28 (10.41) | 0 | 28 (10.81) | |
| 7–15 years | 45 (16.73) | 3 (30.00) | 42 (16.22) | |
| Origin, N (%) | 0.0102 | |||
| CA | 135 (50.19) | 1 (10.00) | 134 (51.74) | |
| HA | 134 (49.81) | 9 (90.00) | 125 (48.26) | |
| Disease | 0.2900 | |||
| Invasive infectionb, N (%) | 80 (29.74) | 1 (10.00) | 9 (90.00) | |
| Non-invasive infectionc, N(%) | 189 (70.26) | 79 (30.50) | 180 (69.50) | |
| Vancomycin treatment, N (%) | 66 (24.54) | 2 (20.00) | 64 (24.71) | 1.0000 |
| Linezolid treatment, N (%) | 45 (16.73) | 2 (20.00) | 43 (16.60) | 0.6758 |
| Hospitalization-Median (IQR) | 15 (10–24) | 21 (10.25–30.25) | 14 (10–23) | 0.4000 |
aIQR interquartile range
bSSTI Including skin and soft tissue infection, BSI bloodstream infection, CNSI central nervous system infection, IE infective endocarditis, BJI bone and joint infection, SP severe pneumonia, AI intra-abdominal infection. Details were as follows: SSTI (1 case), AI (1 case), CNSI (1 case), BJI (3 cases), SP (11 cases), BSI (11 cases), BSI + SSTI (16 cases), BSI + AI (1 case), BSI + IE (4), BSI + BJI (6 cases), BSI + CNSI (2 cases), BSI + SP (5 cases), BJI + SSTI (1 case), SP + SSTI (1 case), SP + BJI (1 case), BSI + SSTI+CNSI (1 case), BSI + CNSI+IE (1 case), BSI + SP + CNSI (1 case), BSI + SP + SSTI (3 cases), BSI + BJI + SSTI (7 cases), BSI + BJI + SSTI+CNSI (1 cases), BSI + SP + SSTI+CNSI (1 case)
cIncluding SSTI (83 cases), pneumonia (103 cases), pneumonia+SSTI (2 cases), urinary system infection (1 case)